1-[4-(prop-2-yn-1-yloxy)phenyl]ethan-1-one, 95%, 250mg

2-[2-(6-Bromohexyloxy)ethoxymethyl]-1,3-dichlorobenzene, 95.0%, 10g

2-Bromo-3-cyclopropylpyridine, 95.0%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhex-4-enoic acid, 98+%, 250mg

2,2-BIS(BROMOMETHYL)-1,3-DIOXOLANE, 97.0%, 1g

(E)-2-(4-(4-(benzo[d]oxazol-2-yl)styryl)phenyl)-5-methylbenzo[d]oxazole, 98%, 25g

3-OXABICYCLO[3.1.0]HEXAN-6-YLMETHANOL, 95.0%, 1g

5,7-dimethyl-1,2,3,4-tetrahydro-1,8-naphthyridine, 95.0%, 250mg

Plan stress-free PLPOLi 100x/0.80 IOS objective for iScope incident polarization, no cover glass correction. Working distance 2 mm

[4-(Trifluoromethyl)phenyl]acetic acid methyl ester, 99.0%, 25g

3-(4-iso-Propyl-phenoxymethyl)-4-methoxy-benzaldehyde, 100mg

4-Chloro-1H-pyrrole-2-carboxylic acid, 95.0%, 5g

1,3,5-Triethynylbenzene>98.0%(GC)5g